BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 14, 2018

Total Value: $3.569B (100.0% shares, 0.0% debt)

Holdings (7)

G GENPACT LIMITED 34.8%

Value $1.241B Shares 40,538,196 Share Price $30.62 Est. Cost/Share — Unrealized @ Report Date —

— MICHAELS COS INC 24.0%

Value $857M Shares 52,798,929 Share Price $16.23 Est. Cost/Share — Unrealized @ Report Date —

IQV IQVIA HLDGS INC 13.9%

Value $495M Shares 3,815,315 Share Price $129.75 Est. Cost/Share — Unrealized @ Report Date —

SGRY SURGERY PARTNERS INC 12.2%

Value $437M Shares 26,455,651 Share Price $16.50 Est. Cost/Share — Unrealized @ Report Date —

— ATENTO S A 10.2%

Value $364M Shares 48,520,671 Share Price $7.50 Est. Cost/Share — Unrealized @ Report Date —

— VERITIV CORP 2.8%

Value $101M Shares 2,783,840 Share Price $36.40 Est. Cost/Share — Unrealized @ Report Date —

— FRANKS INTL N V 2.1%

Value $73.8M Shares 8,506,930 Share Price $8.68 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
G	GENPACT LIMITED	40,538,196	$1.241B	34.8%	$30.62	—	—	SHS	G3922B107
—	MICHAELS COS INC	52,798,929	$857M	24.0%	$16.23	—	—	COM	59408Q106
IQV	IQVIA HLDGS INC	3,815,315	$495M	13.9%	$129.75	—	—	COM	46266C105
SGRY	SURGERY PARTNERS INC	26,455,651	$437M	12.2%	$16.50	—	—	COM	86881A100
—	ATENTO S A	48,520,671	$364M	10.2%	$7.50	—	—	SHS	L0427L105
—	VERITIV CORP	2,783,840	$101M	2.8%	$36.40	—	—	COM	923454102
—	FRANKS INTL N V	8,506,930	$73.8M	2.1%	$8.68	—	—	COM	N33462107